A phase III placebo-controlled study in advanced head and neck cancer using intratumoural cisplatin/epinephrine gel
Open Access
- 21 October 2002
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 87 (9) , 938-944
- https://doi.org/10.1038/sj.bjc.6600588
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Intratumoral cisplatin/adrenaline injectable gel for the treatment of patients with cutaneous and soft tissue metastases of malignant melanomaMelanoma Research, 2003
- Palliation of patients with dysphagia due to advanced esophageal cancer by endoscopic injection of cisplatin/epinephrine injectable gelGastrointestinal Endoscopy, 2002
- CT-guided intratumoural administration of cisplatin/epinephrine gel for treatment of malignant liver tumoursBritish Journal of Cancer, 2002
- Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma.2001
- Percutaneous loco-regional therapy of unresectable hepatocellular carcinoma (HCC) with cisplatin/epinephrine (CDDP/EPI) injectable gelEuropean Journal Of Cancer, 2001
- Management of hepatoma using cisplatin/epinephrine gel in patients awaiting orthotopic liver transplantationTransplantation Proceedings, 2001
- Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual dataThe Lancet, 2000
- Intratumoral cisplatin/epinephrine‐injectable gel as a palliative treatment for accessible solid tumors: A multicenter pilot studyOtolaryngology -- Head and Neck Surgery, 1998
- Tumors: Wounds That Do Not HealNew England Journal of Medicine, 1986
- Power and Sample Size for a Collection of 2 x 2 TablesPublished by JSTOR ,1984